SCHEMBL15528558

SCHEMBL15528558

OCCCCCCOc1ccc(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
RECQL P46063 1/20 0.50
KCNA3 P22001 1/20 0.50
KDM4E B2RXH2 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
HDAC1 Q13547 5/20 0.46
HDAC2 Q92769 5/20 0.46
HDAC3 O15379 3/20 0.46
HDAC4 P56524 3/20 0.46
HDAC7 Q8WUI4 3/20 0.46
HDAC10 Q969S8 3/20 0.46
HDAC11 Q96DB2 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC9 Q9UKV0 3/20 0.46
HDAC5 Q9UQL6 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20492168 0.93 ALDH1A1 (0.53) ALDH1A1RECQLKCNA3KDM4EMEN1
SCHEMBL21847090 0.87 ALDH1A1 (0.67) ALDH1A1RECQLKCNA3KDM4EMEN1
SCHEMBL346390 0.87 ALDH1A1 (0.67) ALDH1A1RECQLKCNA3KDM4EMEN1
SCHEMBL26981901 0.87 KDM4E (0.63) ALDH1A1RECQLKDM4EMEN1KMT2A
SCHEMBL1006520 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL1004974 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL1006073 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL1007090 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL812412 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL1007517 0.83 KCNA3 (0.73) ALDH1A1RECQLKCNA3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2995606-B1 TRITYLATED ETHERS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-03-29 EP disclosed
US-9410100-B2 Tritylated ethers DOW GLOBAL TECHNOLOGIES LLC (US) 2016-08-09 US disclosed
EP-2995606-A1 TRITYLATED ETHERS Dow Global Technologies LLC (US) 2016-03-16 EP disclosed
US-20150128485-A1 TRITYLATED ETHERS DOW GLOBAL TECHNOLOGIES LLC 2015-05-14 US disclosed
EP-2844630-A1 TRITYLATED ETHERS Dow Global Technologies LLC (US) 2015-03-11 EP disclosed
WO-2013165839-A1 TRITYLATED ETHERS ANGUS CHEMICAL COMPANY (US) 2013-11-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150128485-A1 TRITYLATED ETHERS HTR3C, NR3C2, NR3C1 ALDH1A1 2232/4885RECQL 3437/4885KCNA3 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.